These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28810895)

  • 1. Understanding the cluster randomised crossover design: a graphical illustraton of the components of variation and a sample size tutorial.
    Arnup SJ; McKenzie JE; Hemming K; Pilcher D; Forbes AB
    Trials; 2017 Aug; 18(1):381. PubMed ID: 28810895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size calculations for cluster randomised crossover trials in Australian and New Zealand intensive care research.
    Arnup SJ; McKenzie JE; Pilcher D; Bellomo R; Forbes AB
    Crit Care Resusc; 2018 Jun; 20(2):117-123. PubMed ID: 29852850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality.
    Arnup SJ; Forbes AB; Kahan BC; Morgan KE; McKenzie JE
    Trials; 2016 Dec; 17(1):575. PubMed ID: 27923384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A note on sample size calculations for cluster randomised crossover trials with a fixed number of clusters.
    Kelly TL; Pratt N
    Stat Med; 2019 Aug; 38(18):3342-3345. PubMed ID: 31069820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the cluster randomized crossover design in clinical trials: protocol for a systematic review.
    Arnup SJ; Forbes AB; Kahan BC; Morgan KE; McDonald S; McKenzie JE
    Syst Rev; 2014 Aug; 3():86. PubMed ID: 25115725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing appropriate analysis methods for cluster randomised cross-over trials with a binary outcome.
    Morgan KE; Forbes AB; Keogh RH; Jairath V; Kahan BC
    Stat Med; 2017 Jan; 36(2):318-333. PubMed ID: 27680896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculation for stepped wedge and other longitudinal cluster randomised trials.
    Hooper R; Teerenstra S; de Hoop E; Eldridge S
    Stat Med; 2016 Nov; 35(26):4718-4728. PubMed ID: 27350420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate statistical methods were infrequently used in cluster-randomized crossover trials.
    Arnup SJ; Forbes AB; Kahan BC; Morgan KE; McKenzie JE
    J Clin Epidemiol; 2016 Jun; 74():40-50. PubMed ID: 26633599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power and sample size requirements for GEE analyses of cluster randomized crossover trials.
    Li F; Forbes AB; Turner EL; Preisser JS
    Stat Med; 2019 Feb; 38(4):636-649. PubMed ID: 30298551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster randomised trials with different numbers of measurements at baseline and endline: Sample size and optimal allocation.
    Copas AJ; Hooper R
    Clin Trials; 2020 Feb; 17(1):69-76. PubMed ID: 31580144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size calculation for a stepped wedge trial.
    Baio G; Copas A; Ambler G; Hargreaves J; Beard E; Omar RZ
    Trials; 2015 Aug; 16():354. PubMed ID: 26282553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of non-uniform correlation structure on sample size and power in multiple-period cluster randomised trials.
    Kasza J; Hemming K; Hooper R; Matthews J; Forbes AB
    Stat Methods Med Res; 2019 Mar; 28(3):703-716. PubMed ID: 29027505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-cluster and inter-period correlation coefficients for cross-sectional cluster randomised controlled trials for type-2 diabetes in UK primary care.
    Martin J; Girling A; Nirantharakumar K; Ryan R; Marshall T; Hemming K
    Trials; 2016 Aug; 17():402. PubMed ID: 27524396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size calculations for randomised trials including both independent and paired data.
    Yelland LN; Sullivan TR; Price DJ; Lee KJ
    Stat Med; 2017 Apr; 36(8):1227-1239. PubMed ID: 28074483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study.
    Barker D; D'Este C; Campbell MJ; McElduff P
    Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.